2017
DOI: 10.1038/srep45138
|View full text |Cite
|
Sign up to set email alerts
|

Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition

Abstract: Lumican is a small leucine-rich proteoglycan that has been shown to contribute in several physiological processes, but also to exert anticancer activity. On the other hand, it has been recently shown that knockdown of the estrogen receptor α (ERα) in low invasive MCF-7 (ERα+) breast cancer cells and the suppression of ERβ in highly aggressive MDA-MB-231 (ERβ+) cells significantly alter the functional properties of breast cancer cells and the gene expression profile of matrix macromolecules related to cancer pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
49
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(50 citation statements)
references
References 42 publications
1
49
0
Order By: Relevance
“…MDA-MB-231 human cells express this triple-negative immunoprofile and are the main cell line used to investigate this breast cancer subtype 5 , 6 . They are flattened and spindle-like cells with increased cell-cell contacts and an aggressive phenotype 7 . Moreover, the 4T1 murine cells are also typical triple negative breast cancer cell line and closely mimic human breast cancer considering characteristics as anatomical site, immunogenicity and growth development.…”
Section: Introductionmentioning
confidence: 99%
“…MDA-MB-231 human cells express this triple-negative immunoprofile and are the main cell line used to investigate this breast cancer subtype 5 , 6 . They are flattened and spindle-like cells with increased cell-cell contacts and an aggressive phenotype 7 . Moreover, the 4T1 murine cells are also typical triple negative breast cancer cell line and closely mimic human breast cancer considering characteristics as anatomical site, immunogenicity and growth development.…”
Section: Introductionmentioning
confidence: 99%
“…In cancer, lumican attenuates the proliferation, migration, and invasion of breast cancer cells. It modifies cellular junctions and promotes MET 131 through direct interactions with other ECM molecules or by the modulation of membrane receptors 132,133 and MMP-14. [134][135][136] Glypicans are proteoglycans that participate in developmental morphogenesis.…”
Section: Epithelial-mesenchymal Transition: What Is New?mentioning
confidence: 99%
“…Decorin (DCN), biglycan (BGN), fibromodulin (FMO), and lumican (LUM) are the best-characterized members of the SLRP family and have been extensively studied. DCN was found to inhibit downstream oncogenic signaling in several solid tumors by binding and antagonizing various receptor tyrosine kinases [ 18 ]; LUM was reported to have anticancer activity by effectively regulating the estrogen receptor-associated functional properties of breast cancer cells, the expression of matrix effectors, and the epithelial-to-mesenchymal transition [ 19 ].…”
Section: Introductionmentioning
confidence: 99%